EMYRIA

Emyria is poised to drive significant growth by leveraging the cash flows from our thriving clinical services to expand our Empax Centre sites while introducing new advanced services to our suite of offerings. In parallel, We are engaging major health payers to broaden access and coverage for patients, while advancing our drug development programs in a cost-efficient manner via awarded grants. With these strategic initiatives, Emyria is set to accelerate growth, enhance patient impact, and deliver substantial returns for our investors... Mental health is one of our fastest-growing global healthcare challenges, demanding entirely new solutions. At Emyria, we are leading the way by actively evaluating MDMA- and psilocybin-assisted therapies to treat PTSD and treatment-resistant depression, aiming to significantly improve patient outcomes... Emyria's purpose is to optimise patient outcomes and experiences. Operating as a publicly listed entity, we are acutely aware of, and embrace, the..

Primary location: Newcastle